Iwamoto, S., Maeda, H., Hazama, S., Oba, K., Okayama, N., Suehiro, Y., . . . Nagata, N. (2018). Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer. J Cancer.
Chicago ZitierstilIwamoto, Shigeyoshi, et al. "Efficacy of CapeOX Plus Cetuximab Treatment As a First-Line Therapy for Patients With Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer." J Cancer 2018.
MLA ZitierstilIwamoto, Shigeyoshi, et al. "Efficacy of CapeOX Plus Cetuximab Treatment As a First-Line Therapy for Patients With Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer." J Cancer 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.